Addressing Unmet Patient Needs for Small Volume APIs
In this video Dr. Stephen Munk, CEO of Ash Stevens addresses the rise in demand for personalized medicine and accelerated regulatory approval pathways for active pharmaceutical ingredients that meet the needs of unique high risk medical and genetic conditions.
To learn more about Moving Science at Ash Stevens, visit ashstevens.com